• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. CROSSER 14S CTO RX CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. CROSSER 14S CTO RX CATHETER Back to Search Results
Catalog Number CRE14S
Device Problems Detachment Of Device Component (1104); Migration or Expulsion of Device (1395); Material Separation (1562); Detachment of Device or Device Component (2907)
Patient Problems Foreign Body In Patient (2687); No Known Impact Or Consequence To Patient (2692)
Event Date 06/22/2015
Event Type  Injury  
Event Description
It was reported that the marker band of the recanalization catheter allegedly detached from the catheter and remains in the patient.The marker band allegedly migrated to the dorsalis pedis artery without any serious signs of embolization; therefore, it was reported that the physician decided to leave the marker band in the patient and completed the recanalization procedure.There was no known impact or consequence to the patient.
 
Manufacturer Narrative
The lot number for the device has been provided.A review of the device history records is currently being performed.The device had not been returned to the manufacturer for evaluation.The investigation is currently underway.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Manufacturer Narrative
The device history records were reviewed with special attention to the raw materials, subassemblies, manufacturing process and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.This is the only event reported to date for this lot number and failure mode.Visual inspection: the device was returned without product packaging or labeling.The distal tip of the catheter was present and was not detached from the core wire.The distal metal marker band was not present on the catheter and was not returned.A small segment of the marker band was still present on the outer catheter.The outer catheter and inner guidewire lumen were separated from the distal metal tip and the edges of the outer catheter separation were jagged and stretched.Bunching of the catheter was noted near the distal tip.No other anomalies were noted to the returned device.Functional/performance evaluation: no functional testing was performed due to the condition of the returned device.Medical records review: medical records were not provided.Image/photo review: no images/photos were provided.Conclusion: the investigation is confirmed for a marker band detachment, as only a small segment of the marker band was present on the catheter and the remainder of the marker band was not returned for evaluation.The investigation is confirmed for material separation, as the catheter was separated from the distal tip.Per the reported event details, the tip of the catheter got stuck at the distal end of the occlusion during removal.It is likely that excessive force during removal of the catheter, combined with the tip being stuck, resulted in the marker band detaching from the catheter and the outer catheter separating from the distal tip.The definitive root cause for the tip getting stuck in the distal end of the occlusion is unknown.It is unknown whether patient and/or procedural issues contributed to the event.Labeling review: specific warnings, precautions and adverse events associated with the use of the crosser catheter are included in the current instructions for use (ifu).Interventional use: advance the guidewire and crosser catheter 14p, 14s, or 18 to the lesion site.Withdraw the guidewire approximately 1cm within the catheter so that the tip of the crosser catheter is the leading edge.Slowly advance the catheter tip through the lesion.Apply steady, constant pressure so the tip of the catheter is engaged to the lesion.Upon successful recanalization of the lesion, advance the guidewire distal to the lesion and then withdraw the crosser 14p, 14s, or 18 catheter.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CROSSER 14S CTO RX CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 west 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804 2045
Manufacturer Contact
judith ludwig
1625 west 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key4947294
MDR Text Key6190428
Report Number2020394-2015-01218
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K072776
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,foreign,user facility
Reporter Occupation Other
Type of Report Initial
Report Date 06/26/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2016
Device Catalogue NumberCRE14S
Device Lot NumberGFYI3088
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer07/09/2015
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 06/26/2015
Initial Date FDA Received07/22/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/21/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-